Arsenic trioxide: expanding roles for an ancient drug?
Ravandi
F
F
Department of Leukemia, University of Texas -- MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. fravandi@mdanderson.org
D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000188:drug therapy*; D010087:Oxides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016879:Salvage Therapy
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide